Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis
Description
CONCLUSIONS: None of the different types of vaccines were significantly superior in terms of efficacy, while mRNA vaccines were significantly inferior in safety to other types. BNT162b2 had the highest efficacy in preventing symptomatic SARS-CoV-2
